Pyrazinamide USP Antituberculosis Drug from Canada
Pyrazinamide, a pyrazine carboxamide derivative, is explicitly listed in HTS 2933.99.4200 as an anti-infective pharmaceutical. This first-line tuberculosis treatment is imported as pure USP powder for tablet manufacturing. Its aromatic heterocyclic structure with nitrogen hetero-atoms defines its Chapter 29 classification.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Require DMF (Drug Master File) and bioequivalence data for API imports into US tablet production
• TB drugs face heightened FDA scrutiny; ensure GMP certification from manufacturing facility
• Confirm crystal form (polymorph) matches USP monograph to avoid reclassification issues